Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway
Abstract Cisplatin is a widely used chemotherapeutic agent for treatment of various cancers. However, treatment with cisplatin is associated with drug resistance and several adverse side effects such as nephrotoxicity, reduced immunity towards infections and hearing loss. A Combination of cisplatin...
Main Authors: | Iman W. Achkar, Nabeel Abdulrahman, Hend Al-Sulaiti, Jensa Mariam Joseph, Shahab Uddin, Fatima Mraiche |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-04-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12967-018-1471-1 |
Similar Items
-
Mitogen Activated Protein kinase signal transduction pathways in the prostate
by: Koul Sweaty, et al.
Published: (2004-06-01) -
Thrombomodulin Regulation of Mitogen-Activated Protein Kinases
by: Hemant Giri, et al.
Published: (2019-04-01) -
Overcoming Limitations of Cisplatin Therapy by Additional Treatment With the HSP90 Inhibitor Onalespib
by: Anja Charlotte Lundgren Mortensen, et al.
Published: (2020-09-01) -
Role of mitogen-activated protein kinases in vascular relaxation in porcine coronary arteries
by: Chiu, Tsz-ling, et al.
Published: (2014) -
Signaling pathways in myocyte hypertrophy:role of GATA4, mitogen-activated protein kinases and protein kinase C
by: Kerkelä, R. (Risto)
Published: (2003)